Powder Filled Vials

Powder Filled Vials
Product Description

Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing products which includes powder filled vials. It is a type of cytotoxics. It offers filling of powder filled vials at our highly experienced Halle/Westfalen, Germany facility. In addition to continuous monitoring of temperature, relative humidity, laminar air flow, differential pressure and non-viable airborne particles in the isolator. Sizes and options: clinical to commercial scale; starting from 1 kg of powder; vial sizes from 6 to 100 ml validated; fill weight: 50 mg/vial to 5 g/vial; 1 – 8 filling heads. Advanced processing: class 100 (iso 5) isolator; isolator sterilization by vaporized hydrogen peroxide (vhp); cip/sip of powder hopper; 100% fill weight check or in-process fill weight check; auger fillers designed for precise powder dosing; online visual inspection; vial printing; packaging robot for bulk packaging of drug product vials.

Baxter Healthcare Corporation

  • US
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Contract Service

Baxter Healthcare Corporation

  • US
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Contract Service

More Products from Baxter Healthcare Corporation (4)

  • Prefilled Syringes

    Product Prefilled Syringes

    Baxter (BioPharma Solutions) offers a wide range of traditional sterile manufacturing products which includes prefilled syringes. It offers expanded small-scale through high-volume sterile manufacturing. It can increase production potential and help ensure on-time delivery to meet product demand. By providing...
  • Lyophilized Vials

    Product Lyophilized Vials

    Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing/traditional sterile manufacturing products which includes lyophilized vials. The process of freeze drying can achieve product stability, and improved shelf-life. It offers individual filling suites with lyophilization capacity, ...
  • Liquid Vials

    Product Liquid Vials

    Baxter (BioPharma Solutions) offers a wide range of traditional sterile manufacturing products which includes liquid vials. It can helps clients to meet developmental, clinical, and commercial liquid vial manufacturing needs. High-volume filling and multiple, dedicated vial-filling suites allow to expand prod...
  • Diluents for Reconstitution

    Product Diluents for Reconstitution

    Baxter (BioPharma Solutions) offers a wide range of traditional sterile manufacturing products which includes diluents for reconstitution. It offer both customer and patient benefits. When compared to vials, they can enhance and improve patient safety such as less steps for reconstitution; reduced contaminati...

Baxter Healthcare Corporation resources (6)

  • Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner

    In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection.
  • Brochure A Global Leader in Sterile Contract Manufacturing

    Our processes and systems are tailored to meet your parenteral manufacturing needs. We offer conventional sterile dosage forms, including prefilled syringes, liquid vials, lyophilized vials and cartridges as well as cost-saving diluents for reconstitution.
  • Whitepaper Seasonal Vaccine Manufacturing

    The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting from annual strain selection. The limited-time span from strain selection to distribution requires most vaccine producers to rely on outsourcing partners to ensure timely production and supply. While the right facility and technical expertise are important, vaccine developers should also focus on securing a culture of speed and execution, shared expectations, and continuous improvement. This whitepaper from Baxter’s contract manufacturing business, BioPharma Solutions examines three key areas to evaluate when selecting an outsourcing partner for vaccines production to ensure quality and on-time delivery.
  • Podcast CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner

    In this episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection.
  • Webinar Rapid Tech Transfer of Vaccine Products

    The compressed timelines for technical transfer of COVID-19 projects were unprecedented and offered opportunities to identify and reflect on the unique capabilities required to meet these timelines, as well as the best practices applied to result in the fastest path to GMP production and supply reliability. This webinar is an opportunity for pharmaceutical companies to better understand how the selection of the right CMO is key not only save cost, but also time. Join us to learn more about why the following criteria are so important when selecting a CMO: Responsive and Expansive Supplier Networks Global Manufacturing and Regulatory Experience Collaborative Decision Making Experience and Agility Scientific Expertise
  • Webinar Common Stumbling Blocks When Outsourcing an Injectable Project to a CMO & How to Avoid Them

    With the recent growth in demand for injectables (due to the COVID-19 pandemic and an increased reliance on biologics to treat chronic diseases) and a tightening of the capacity available, many biotech and pharma companies are having to outsource the manufacturing of their drug products. Yet many have limited-to-no experience working with a CMO. They often do not know what to look for in a vendor or when is the right time to engage with them. They tend to reach out too early before they have the critical information necessary for a CMO to properly define the scope of the project, which can waste valuable time. This webinar is meant to provide Best Practices on what pharma clients need to have established prior to requesting a proposal from a CMO and how to have an effective kick off meeting to ensure a streamlined transfer.